Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

432 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Stroke severity, early recovery and outcome are each related with clinical classification of stroke: data from the 'Tinzaparin in Acute Ischaemic Stroke Trial' (TAIST).
Sprigg N, Gray LJ, Bath PM, Lindenstrøm E, Boysen G, De Deyn PP, Friis P, Leys D, Marttila R, Olsson JE, O'Neill D, Ringelstein EB, van der Sande JJ, Turpie AG; TAIST Investigators. Sprigg N, et al. Among authors: turpie ag. J Neurol Sci. 2007 Mar 15;254(1-2):54-9. doi: 10.1016/j.jns.2006.12.016. Epub 2007 Jan 29. J Neurol Sci. 2007. PMID: 17258770 Free article. Clinical Trial.
Early recovery and functional outcome are related with causal stroke subtype: data from the tinzaparin in acute ischemic stroke trial.
Sprigg N, Gray LJ, Bath PM, Lindenstrøm E, Boysen G, De Deyn PP, Friis P, Leys D, Marttila R, Olsson JE, O'Neill D, Ringelstein EB, van der Sande JJ, Turpie AG; TAIST Investigators. Sprigg N, et al. Among authors: turpie ag. J Stroke Cerebrovasc Dis. 2007 Jul-Aug;16(4):180-4. doi: 10.1016/j.jstrokecerebrovasdis.2007.02.003. J Stroke Cerebrovasc Dis. 2007. PMID: 17689415
Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial.
Cools F, Virdone S, Sawhney J, Lopes RD, Jacobson B, Arcelus JI, Hobbs FDR, Gibbs H, Himmelreich JCL, MacCallum P, Schellong S, Haas S, Turpie AGG, Ageno W, Rocha AT, Kayani G, Pieper K, Kakkar AK; ETHIC investigators. Cools F, et al. Lancet Haematol. 2022 Aug;9(8):e594-e604. doi: 10.1016/S2352-3026(22)00173-9. Epub 2022 Jun 30. Lancet Haematol. 2022. PMID: 35779560 Free PMC article. Clinical Trial.
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.
Cohen AT, Davidson BL, Gallus AS, Lassen MR, Prins MH, Tomkowski W, Turpie AG, Egberts JF, Lensing AW; ARTEMIS Investigators. Cohen AT, et al. Among authors: turpie ag. BMJ. 2006 Feb 11;332(7537):325-9. doi: 10.1136/bmj.38733.466748.7C. Epub 2006 Jan 26. BMJ. 2006. PMID: 16439370 Free PMC article. Clinical Trial.
Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison.
Lassen MR, Bauer KA, Eriksson BI, Turpie AG; European Pentasaccharide Elective Surgery Study (EPHESUS) Steering Committee. Lassen MR, et al. Among authors: turpie ag. Lancet. 2002 May 18;359(9319):1715-20. doi: 10.1016/S0140-6736(02)08652-X. Lancet. 2002. PMID: 12049858 Clinical Trial.
432 results